发明名称 |
RESPONSIVENESS TO ANGIOGENESIS INHIBITORS |
摘要 |
The invention is concerned with a method of determining whether a patient is more suitably treated by a therapy with an angiogenesis inhibitor, such as bevacizumab, by determining the genotype of VEGFR-1 gene. The invention further relates to a pharmaceutical composition comprising an angiogenesis inhibitor, such as bevacizumab, for the treatment of a patient suffering from cancer based on the genotype of VEGFR-1 gene. The invention further relates to a method for improving the treatment effect of chemotherapy of a patient suffering from cancer by adding an angiogenesis inhibitor, such as bevacizumab, based on the genotype of VEGFR-1 gene. |
申请公布号 |
US2015004136(A1) |
申请公布日期 |
2015.01.01 |
申请号 |
US201414284746 |
申请日期 |
2014.05.22 |
申请人 |
Hoffmann-La Roche Inc. ;VIB vzw ;Life Sciences Research Partners vzw |
发明人 |
Carmeliet Peter;de Haas Sanne Lysbet;Lambrechts Diether;Scherer Stefan |
分类号 |
C07K16/22;A61K45/06;C12Q1/68;A61K39/395 |
主分类号 |
C07K16/22 |
代理机构 |
|
代理人 |
|
主权项 |
1. An in vitro method of determining whether a patient suffering from cancer or physiological or pathological angiogenic abnormalities is suitably treated by a therapy with an angiogenesis inhibitor comprising bevacizumab or an antibody that binds essentially the same epitope on VEGF as bevacizurnab, said method comprising:
(a) determining in a sample derived from a patient suffering from cancer or physiological or pathological angiogenic abnormalities the genotype at the synonymous T/C SNP located in exon 28 of VEGFR-1 corresponding respectively to TAT codon and TAC codon for tyrosine at position 1213, and (b) identifying said patient as more or less suitably treated by a therapy with an angiogenesis inhibitor comprising bevacizumab or an antibody that binds essentially the same epitope on VEGF as bevacizumab based on said genotype, wherein the presence of each T allele at said SNP indicates an increased likelihood that the patient is more suitably treated, or the presence of each C allele at said SNP indicates an increased likelihood that the patient is less suitably treated. |
地址 |
Little Falls NJ US |